These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3592631)

  • 1. Transplantable human non-Hodgkin lymphoma line in artificially immunesuppressed mice.
    Kopper L; Nagy P; Revesz T; Major J; Magyarosy E; Lapis K
    Anticancer Res; 1987; 7(2):193-8. PubMed ID: 3592631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of human non-Hodgkin lymphoma (NHL) xenografts.
    Kopper L; Nagy P; Magyarosy E; Major J
    Acta Morphol Hung; 1986; 34(4):289-97. PubMed ID: 3118646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characteristics of three human non-Hodgkin lymphoma lines: flow cytometric analysis after long-term maintenance.
    Kopper L; Bánkfalvi A; Mihalik R; Páloczi K; Benczur M; Lapis K
    Clin Exp Immunol; 1988 Nov; 74(2):295-9. PubMed ID: 3224446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New in vitro line from a human (B) non-Hodgkin lymphoma.
    Kopper L; Bankfalvi A; Mihalik R; Nagy P; Fulop C; Sarmay G
    Anticancer Res; 1991; 11(4):1645-9. PubMed ID: 1720940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary non-Hodgkin lymphoma of the prostate: a case report].
    Maeda N; Nishizaki S; Furubayashi T
    Hinyokika Kiyo; 1996 Jul; 42(7):537-8. PubMed ID: 8809566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
    Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell lymphoma in the parotid region after cardiac transplant: case report.
    Mandel L; Surattanont F; Dourmas M
    J Oral Maxillofac Surg; 2001 Jun; 59(6):673-7. PubMed ID: 11381393
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
    Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
    Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
    Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior antitumor activity of SAR3419 to rituximab in xenograft models for non-Hodgkin's lymphoma.
    Al-Katib AM; Aboukameel A; Mohammad R; Bissery MC; Zuany-Amorim C
    Clin Cancer Res; 2009 Jun; 15(12):4038-45. PubMed ID: 19509168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment and characterization of a xenografted human cervical carcinoma in nude mice and homologous cell line in vitro].
    Zhao X; Zhang Y; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Apr; 32(4):217-21. PubMed ID: 9596902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.
    Pagel JM; Laugen C; Bonham L; Hackman RC; Hockenbery DM; Bhatt R; Hollenback D; Carew H; Singer JW; Press OW
    Clin Cancer Res; 2005 Jul; 11(13):4857-66. PubMed ID: 16000584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of primary malignant lymphoma of the bladder].
    Nishida S; Kuroko K; Hoshino T; Iwamoto T; Shirai C
    Hinyokika Kiyo; 1998 Aug; 44(8):599-601. PubMed ID: 9783199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of non-Hodgkin malignant lymphomas].
    Gociu M; Coliţă D; Leahu S; Ciocoiu A; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):1-10. PubMed ID: 6145200
    [No Abstract]   [Full Text] [Related]  

  • 19. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation and characterization of cultured tumor lines from spontaneous reticulum cell sarcoma of SJL/J mice.
    Owens MH; Bonavida B
    Cancer Res; 1977 Dec; 37(12):4439-48. PubMed ID: 336194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.